Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the ...
Christian Howell, CEO of Cognito Therapeutics, sits down with Nasdaq’s Kristina Ayanian to discuss the company’s breakthrough approach to treating Alzheimer’s using light and sound stimulation. From ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results